Author

Milada Zemanová

Observed names: M Zemanova, M Zemanová, M. Zemanova, M. Zemanová, MILADA ZEMANOVA, Milada Zemanova, Zemanova Milada, Zemanová M, Zemanová Milada

Institutions: Charles University, General University Hospital in Prague

Observed institutions: Memorial Sloan Kettering Cancer Center, Chungbuk National University, Yonsei University, Charles University, Masaryk University, Aarhus University Hospital, Centre Hospitalier Universitaire de Bordeaux, University of South Bohemia in České Budějovice, Zhengzhou University, Peking University Cancer Hospital, University Hospital Brno, University Hospital Olomouc, University Hospital Plzen, AstraZeneca (Poland), Henan Cancer Hospital, General University Hospital in Prague, University of Pennsylvania

ORCID: 0000-0002-1904-1035

Observed ORCID: 0000-0002-1904-1035

OpenAlex ID: A5089400207

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

2019 · Luis Paz-Ares, Mikhail Dvorkin, et al. · The Lancet · 2,281

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

2020 · Jonathan W Goldman, Mikhail Dvorkin, et al. · The Lancet Oncology · 688

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study

2004 · Petr Zatloukal, Lubos Petruzelka, et al. · Lung Cancer · 428

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma

2017 · Robert J. Motzer, Naomi B. Haas, et al. · Journal of Clinical Oncology · 382

Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer

2024 · Ying Cheng, David R. Spigel, et al. · New England Journal of Medicine · 360

PDF

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

2024 · Myung-Ju Ahn, Kentaro Tanaka, et al. · Journal of Clinical Oncology · 237

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

2003 · Petr Zatloukal, Luboš Petruželka, et al. · Lung Cancer · 160

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

2022 · Nicholas J. Vogelzang, Tomasz M. Beer, et al. · JAMA Oncology · 98

Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer

2020 · MARTIN SVATON, MILADA ZEMANOVA, et al. · Anticancer Research · 89

PDF

Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1

2023 · B. Besse, E. Felip, et al. · Annals of Oncology · 80

LBA1 Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III NSCLC: Final results from PACIFIC-2

2024 · J.D. Bradley, S. Sugawara, et al. · ESMO Open · 76

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study

2025 · Jeffrey D. Bradley, Shunichi Sugawara, et al. · Journal of Clinical Oncology · 75

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial

2021 · Robert J. Motzer, Paul Russo, et al. · European Urology · 68

Diagnostic and prognostic potential of miR-21, miR-29c, miR-148 and miR-203 in adenocarcinoma and squamous cell carcinoma of esophagus

2015 · Renata Hezova, Alena Kovarikova, et al. · Diagnostic Pathology · 53

PDF

Gemcitabine plus Cisplatin versus Gemcitabine plus Carboplatin in Stage IIIb and IV Non Small Lung Cancer: A phase III Randomized Trial

2003 · Petr Zatloukal, Luboš Petruželka, et al. · Lung Cancer · 46

Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis

2015 · Tomas Buchler, Zbynek Bortlicek, et al. · European Urology · 43

Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer

2018 · MARTIN SVATON, MILADA ZEMANOVA, et al. · Anticancer Research · 41

PDF

Molecular characterization and heterogeneity of circulating tumor cells in breast cancer

2017 · Anna Jakabova, Zuzana Bielcikova, et al. · Breast Cancer Research and Treatment · 38

PDF

MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus

2015 · Renata Hezova, Alena Kovarikova, et al. · Tumor Biology · 35

Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study

2014 · D. Jäger, J.H. Ma, et al. · Clinical Genitourinary Cancer · 35

Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with locally advanced renal cell carcinoma (RCC) (PROTECT).

2017 · Robert J. Motzer, Naomi B. Haas, et al. · Journal of Clinical Oncology · 33

O-262 Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer. A randomized phase II study — long-term follow-up data

2003 · Petr Zatloukal, Lubos Petruzelka, et al. · Lung Cancer · 33

Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis

2019 · Tanja Cufer, Tudor E. Ciuleanu, et al. · The Oncologist · 25

PDF

Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up

2009 · M. Zemanova, L. Petruzelka, et al. · Diseases of the Esophagus · 23

Efficacy of Sunitinib in Elderly Patients with Metastatic Renal Cell Carcinoma: Data from Real-World Clinical Practice

2016 · On behalf of the Czech Renal Cell Cancer Cooperative Group, Alexandr Poprach, et al. · Drugs & Aging · 19

Works count: 168

Citation count: 5,851

H-index: 24

I10-index: 41